SAFE Laboratories Act Stop Adversarial Funding Expenditures for Laboratories Act
Impact
If enacted, HB 1373 would strengthen the federal government's ability to control the flow of funding and resources to certain foreign laboratories that could pose risks to U.S. interests. This bill reflects a broader trend in U.S. policy aimed at distancing itself from collaborations that may compromise national security. Supporters argue that it is essential for protecting American citizens from potential threats associated with research entities in countries known for their adversarial stances towards the United States.
Summary
House Bill 1373, also known as the SAFE Laboratories Act, seeks to prohibit any head of a Federal agency from providing assistance, either directly or indirectly, to the Wuhan Institute of Virology and other laboratories located in nations classified as foreign adversaries, including China, Russia, North Korea, and Iran. This legislation is a response to growing concerns about the security and accountability of U.S. funding to foreign research facilities, particularly in the context of public health and national security threats posed by these adversarial nations.
Contention
However, the bill may also invite debate regarding the potential implications for scientific collaboration and public health research globally. Some opponents might argue that such restrictions could hinder beneficial international partnerships that promote global health security and advancements in scientific research. Additionally, the scope of defining 'foreign adversaries' could raise questions about how broadly these provisions will be applied and what oversight mechanisms will be put in place to ensure they do not stifle legitimate cooperative endeavors.
Requires hospital laboratories and bio-analytical or clinical laboratories to offer test for hepatitis C to certain individuals; authorizes certain laboratories to perform rapid tests for hepatitis C.